Pages
Products

Recombinant Human TNFRSF1A (C-Fc)

For research use only. Not intended for any clinical use.

Cat. No. :   RP00632 Tag :   C-Fc

Expressed Region :   Leu30-Thr211 Expression System :   Human Cell

Inquire for Price

Product Information

Gene Information

Cat. No. RP00632
Description Recombinant Human TNFRSF1A (C-Fc) is produced in our Human Cell expression system. The amino acid region expressed is Leu30-Thr211 with a Fc tag at the C terminus.
Species Human
Tag C-Fc
Mol Weight 47.2 KDa
Conjugate Unconjugated
Format Powder
Expressed Region Leu30-Thr211
Expression System Human Cell
Formulation Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Purity >95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Endotoxin Level < 1 EU/µg of protein by LAL method
Storage Upon receipt, this product is stable for up to 6 months at temperatures below -70°C. Once reconstituted, the product is stable for up to 1 week at 4°C and up to 3 months at -20°C. Please avoid repeated freeze-thaw cycles.
Shipping The product is shipped with ice packs. Upon receipt, store it immediately at the temperature recommended below.
Reconstitution Always centrifuge tubes before opening. It is recommended to reconstitute the solution to a concentration above 100 μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
Target Gene TNFRSF1A
Synonyms Tumor necrosis factor receptor superfamily member 1A;TNFRSF1A;Tumor necrosis factor receptor 1; TNF-R1; TNF-RI; p55; p60; CD120a; TNFAR; TNFR1
Quick Inquiry

Background

Q & A

Customer Reviews

This gene encodes a member of the TNF receptor superfamily of proteins. The encoded receptor is found in membrane-bound and soluble forms that interact with membrane-bound and soluble forms, respectively, of its ligand, tumor necrosis factor alpha. Binding of membrane-bound tumor necrosis factor alpha to the membrane-bound receptor induces receptor trimerization and activation, which plays a role in cell survival, apoptosis, and inflammation. Proteolytic processing of the encoded receptor results in release of the soluble form of the receptor, which can interact with free tumor necrosis factor alpha to inhibit inflammation. Mutations in this gene underlie tumor necrosis factor receptor-associated periodic syndrome (TRAPS), characterized by fever, abdominal pain and other features. Mutations in this gene may also be associated with multiple sclerosis in human patients.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction